In addition to Aβ pathology, several lines of evidence have shown that insulin deficiency in the brains of STZ-treated APP transgenic mice increases tau phosphorylation. The gene discussed is MAPT; the disease is hyperinsulinemic hypoglycemia, familial, 4.